Effect of neoadjuvant chemotherapy on surgical outcomes in Danish breast cancer patients between 2018-2023.
INTRODUCTION Neoadjuvant chemotherapy (NACT) has been used nationwide in Denmark to downsize tumour and for downstaging of metastases in the axilla. Although several studies have assessed the impact of NACT on surgical complications after immediate breast reconstruction (IBR), the available evidence remains inconsisten...